Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-emptive dexmedetomidine dosing for postoperative pain, nausea, and vomiting after laparoscopic cholecystectomy
IRCT20101211005362N31Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of dexmedetomidine in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Postoperative pain intensity and Postoperative nausea and vomiting. Started Jul 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20101211005362N31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101211005362N31.